Key Points
- CEO Jeffrey Alan Hawkins sold shares: Hawkins sold 12,149 shares on March 23 at an average of $0.83 (and 11,628 shares on March 20 at $0.85), trimming his stake by about 0.3% to 3,859,847 shares; other insiders (a director and the CFO) also made modest open‑market sales the same week.
- Company financials remain weak despite a small EPS beat: QSI trades around $0.80–$0.90 with a $187M market cap, reported ($0.08) EPS beating estimates but missed revenue expectations and shows very negative margins and ROE.
- Mixed analyst and institutional backdrop: Analysts' ratings are mixed (consensus "Hold" with a $3.25 target) while institutions own about 39.9% of the stock, led by Vanguard and others who recently adjusted positions.
Quantum-Si Incorporated (NASDAQ:QSI - Get Free Report) CEO Jeffrey Alan Hawkins sold 12,149 shares of the business's stock in a transaction dated Monday, March 23rd. The shares were sold at an average price of $0.83, for a total transaction of $10,083.67. Following the completion of the transaction, the chief executive officer owned 3,859,847 shares in the company, valued at $3,203,673.01. The trade was a 0.31% decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available through this hyperlink.
Jeffrey Alan Hawkins also recently made the following trade(s):
- On Friday, March 20th, Jeffrey Alan Hawkins sold 11,628 shares of Quantum-Si stock. The stock was sold at an average price of $0.85, for a total transaction of $9,883.80.
Quantum-Si Stock Performance
QSI opened at $0.87 on Thursday. The stock has a market capitalization of $187.16 million, a PE ratio of -1.66 and a beta of 3.00. Quantum-Si Incorporated has a one year low of $0.79 and a one year high of $3.10. The business's 50 day moving average price is $1.02 and its 200 day moving average price is $1.35.
Quantum-Si (NASDAQ:QSI - Get Free Report) last posted its earnings results on Tuesday, March 3rd. The company reported ($0.08) EPS for the quarter, beating analysts' consensus estimates of ($0.14) by $0.06. The company had revenue of $0.45 million for the quarter, compared to the consensus estimate of $0.76 million. Quantum-Si had a negative return on equity of 43.90% and a negative net margin of 4,160.06%. As a group, equities research analysts forecast that Quantum-Si Incorporated will post -0.65 earnings per share for the current fiscal year.
Quantum-Si News Roundup
Here are the key news stories impacting Quantum-Si this week:
- Neutral Sentiment: Public filings show short‑interest data for March 24 reporting "0" shares and anomalous "NaN" changes — likely a data/reporting issue or no reported short positions. The print is ambiguous and should be treated cautiously rather than as a clear bullish or bearish signal.
- Negative Sentiment: CEO Jeffrey Hawkins disclosed small open‑market sales on March 20 and March 23 (about 23,777 shares total at ~$0.83–$0.85; roughly $20k aggregate), reducing his stake by ~0.3% — sales are small relative to his remaining holdings but can be viewed negatively by traders watching insider behavior. SEC Form 4 - Hawkins
- Negative Sentiment: Director/insider John S. Vieceli sold ~21,997 shares across March 20 and March 23 at similar prices (~$0.83–$0.85), trimming his stake by ~0.9%. These are modest dollar amounts but add to the pattern of insider liquidity. SEC Form 4 - Vieceli
- Negative Sentiment: CFO Jeffry R. Keyes sold ~8,655 shares across the same two dates (~$0.83–$0.85), a ~0.23–0.24% trim to his holdings. Combined with other officer/director selling, this increases short‑term negative sentiment even though the sales are small in dollar terms. SEC Form 4 - Keyes
Institutional Inflows and Outflows
A number of institutional investors have recently made changes to their positions in the business. Vanguard Group Inc. lifted its holdings in Quantum-Si by 0.5% during the 3rd quarter. Vanguard Group Inc. now owns 8,714,507 shares of the company's stock worth $12,287,000 after buying an additional 44,846 shares in the last quarter. Geode Capital Management LLC increased its position in shares of Quantum-Si by 9.8% during the fourth quarter. Geode Capital Management LLC now owns 4,114,375 shares of the company's stock worth $4,527,000 after acquiring an additional 367,206 shares during the period. Millennium Management LLC acquired a new stake in shares of Quantum-Si in the first quarter valued at $4,721,000. State Street Corp boosted its holdings in Quantum-Si by 26.5% in the fourth quarter. State Street Corp now owns 3,562,721 shares of the company's stock valued at $3,919,000 after purchasing an additional 745,231 shares during the period. Finally, Squarepoint Ops LLC acquired a new position in Quantum-Si during the 3rd quarter worth $865,000. Institutional investors and hedge funds own 39.90% of the company's stock.
Wall Street Analysts Forecast Growth
QSI has been the topic of several recent analyst reports. Canaccord Genuity Group decreased their price objective on shares of Quantum-Si from $1.50 to $1.00 and set a "hold" rating on the stock in a report on Wednesday, March 4th. Weiss Ratings reiterated a "sell (d-)" rating on shares of Quantum-Si in a report on Monday, December 29th. Two investment analysts have rated the stock with a Buy rating, one has issued a Hold rating and one has given a Sell rating to the company's stock. Based on data from MarketBeat, Quantum-Si has an average rating of "Hold" and a consensus price target of $3.25.
Get Our Latest Research Report on QSI
Quantum-Si Company Profile
(
Get Free Report)
Quantum-Si Inc is a life sciences instrumentation company headquartered in Guilford, Connecticut, developing next-generation proteomics solutions based on semiconductor sequencing technology. The company’s core offering centers on a proprietary single-molecule protein sequencing platform that uses a silicon-based sensor chip to convert protein data into digital signals. This approach is designed to deliver high sensitivity, single-amino-acid resolution and deep proteome coverage while potentially reducing cost and complexity compared to traditional mass spectrometry methods.
Quantum-Si’s product roadmap includes the development and commercialization of an integrated system comprising instruments, consumable reagents and proprietary data analysis software.
Featured Articles
This instant news alert was generated by narrative science technology and financial data from InsiderTrades.com in order to provide readers with the fastest and most accurate reporting. Please send any questions or comments about this story to [email protected].
